Science Explorer Back to mapMap

Kelly Johnson‐Wood

Kelly Johnson‐Wood publishes mostly in Physiology, Molecular Biology and Neurology, on topics such as Alzheimer's disease research and treatments, Prion Diseases and Protein Misfolding and Amyloidosis: Diagnosis, Treatment, Outcomes.

OpenAlex
World rank
#520,374
of 7,710,434 ranked researchers
Rank in United States
#180,764
of 1,627,098
Works
26
Citations
15k
Citations per work
589.5

What does Kelly Johnson‐Wood research?

Kelly Johnson‐Wood's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (28%), Neuroscience (9%).

Life Sciences37%Physical Sciences5%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1036.9%
    1. Biochemistry, Genetics and Molecular Biology727.6%
    2. Neuroscience29.2%
  1. Everything else521.0%
    1. Computer Science15.3%
  1. 1Physiology30% of their works
  2. 2Molecular Biology28% of their works
  3. 3Neurology7% of their works
  4. 4Pharmacology7% of their works
  5. 5Computational Theory and Mathematics5% of their works
  6. 6Cellular and Molecular Neuroscience3% of their works

Research topics

Which keywords describe Kelly Johnson‐Wood's research?

The keywords of their largest research topics: Neurodegeneration, Neuroinflammation, Oxidative Stress, Amyloid Hypothesis, Tau Pathology, Neurodegenerative Diseases, Molecular Basis and Prion Diseases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Neurodegeneration303 topics
  2. Neuroinflammation293 topics
  3. Oxidative Stress252 topics
  4. Amyloid Hypothesis231 topic
  5. Tau Pathology231 topic
  6. Neurodegenerative Diseases132 topics
  7. Molecular Basis81 topic
  8. Prion Diseases81 topic
  9. Cardiac Amyloidosis71 topic
  10. Innate Immunity72 topics
  11. Transthyretin71 topic
  12. Cytokines62 topics
  13. Microglia62 topics
  14. Acetylcholinesterase51 topic
  15. Cholinesterase Inhibitors51 topic
  16. Astrocytes41 topic
  17. Molecular Docking41 topic
  18. Synaptic Pruning41 topic
  19. Virtual Screening41 topic
  20. Inflammation31 topic
  21. S100 Proteins31 topic
  22. Depression21 topic
  23. Tryptophan Metabolism21 topic

Where does Kelly Johnson‐Wood work?

Kelly Johnson‐Wood's main affiliation in the publication record is Athena Group (United States), United States.

How many publications and citations does Kelly Johnson‐Wood have?

OpenAlex counts 26 works and 15,327 citations for Kelly Johnson‐Wood, an h-index of 21, ranking #520,374 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kelly Johnson‐Wood. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.